Low seroprevalence of neutralizing antibodies to adeno-associated virus serotype 9 in preparation for MyPEAK-1 study of TN-201 for individuals with MYBPC3-associated hypertrophic cardiomyopathy
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Tenaya Therapeutics, South San Francisco (United States of America)
5 More presentations in this session
Doctor A. Paldino (Trieste, IT)
Doctor A. Aguiar Neves (Vila Nova de Gaia, PT)
Doctor A. Aguiar Neves (Vila Nova de Gaia, PT)
Doctor M. Bjorkenstam (Gothenburg, SE)
Doctor R. Coderre (Rochester, US)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
